These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12130920)

  • 1. Best supportive care versus palliative chemotherapy in nonsmall-cell lung cancer.
    Medley L; Cullen M
    Curr Opin Oncol; 2002 Jul; 14(4):384-8. PubMed ID: 12130920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy versus best supportive care for advanced non-small-cell lung cancer.
    Abang AM
    Am J Health Syst Pharm; 1996 Dec; 53(24):2980-4. PubMed ID: 8974162
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapy versus best supportive care in stage IV non-small cell lung cancer, non metastatic to the brain.
    Anelli A; Lima CA; Younes RN; Gross JL; Fogarolli R
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(2):53-8. PubMed ID: 11460205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beyond "second-line" in non-small cell lung cancer: therapy and supportive care.
    Martins RG; Reynolds CH; Riely GJ
    Am Soc Clin Oncol Educ Book; 2015; ():e414-8. PubMed ID: 25993204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy versus palliative care in non-small cell lung cancer.
    Nicum S; Cullen MH
    Anticancer Drugs; 2000 Sep; 11(8):603-7. PubMed ID: 11081450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy.
    Thongprasert S; Sanguanmitra P; Juthapan W; Clinch J
    Lung Cancer; 1999 Apr; 24(1):17-24. PubMed ID: 10403690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits of chemotherapy for quality of life in patients with advanced nonsmall-cell lung cancer.
    Paesmans M
    Curr Opin Oncol; 2002 Jul; 14(4):389-93. PubMed ID: 12130921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Do Elderly Poor Prognosis Patients Tolerate Palliative Concurrent Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer Stage III? A Subset Analysis From a Clinical Phase III Trial.
    Strøm HH; Bremnes RM; Sundstrøm SH; Helbekkmo N; Aasebø U
    Clin Lung Cancer; 2015 May; 16(3):183-92. PubMed ID: 25481662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lung cancer in the elderly: so many patients, so little time!
    Balducci L
    CA Cancer J Clin; 2003; 53(6):322-4. PubMed ID: 15224972
    [No Abstract]   [Full Text] [Related]  

  • 10. Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer.
    Cartei G; Cartei F; Cantone A; Causarano D; Genco G; Tobaldin A; Interlandi G; Giraldi T
    J Natl Cancer Inst; 1993 May; 85(10):794-800. PubMed ID: 8387607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy in elderly patients with nonsmall cell lung cancer.
    Veluswamy RR; Levy B; Wisnivesky JP
    Curr Opin Pulm Med; 2016 Jul; 22(4):336-43. PubMed ID: 27100301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference?
    Ganz PA; Figlin RA; Haskell CM; La Soto N; Siau J
    Cancer; 1989 Apr; 63(7):1271-8. PubMed ID: 2465815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What constitutes best supportive care in the treatment of advanced non-small cell lung cancer patients?--Results from the lung cancer economics and outcomes research (LUCEOR) study.
    Lester JF; Agulnik J; Akerborg O; Chouaid C; De Geer A; Finnern HW; Herder GJ; Lungershausen J; Mitchell PL; Vansteenkiste J; Ziske C; Goker E
    Lung Cancer; 2013 Oct; 82(1):128-35. PubMed ID: 23910909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative systemic therapy for advanced non-small cell lung cancer: Investigating disparities between patients who are treated versus those who are not.
    Brule SY; Al-Baimani K; Jonker H; Zhang T; Nicholas G; Goss G; Laurie SA; Wheatley-Price P
    Lung Cancer; 2016 Jul; 97():15-21. PubMed ID: 27237022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of advanced non-small-cell lung cancer (take home message).
    Pirker R
    Lung Cancer; 2004 Aug; 45 Suppl 2():S259-62. PubMed ID: 15552808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment principles in advanced non-small-cell lung cancer.
    Scott CL; Zalcberg JR; Irving LB
    Aust N Z J Surg; 1996 Oct; 66(10):688-93. PubMed ID: 8855925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of quality of life in the supportive care setting of the big lung trial in non-small-cell lung cancer.
    Brown J; Thorpe H; Napp V; Fairlamb DJ; Gower NH; Milroy R; Parmar MK; Rudd RM; Spiro SG; Stephens RJ; Waller D; West P; Peake MD
    J Clin Oncol; 2005 Oct; 23(30):7417-27. PubMed ID: 16157935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for stage IV non-small cell lung cancer.
    Bitran JD; Vokes EE
    Hematol Oncol Clin North Am; 1990 Dec; 4(6):1159-68. PubMed ID: 1704879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The International Atomic Energy Agency (IAEA) randomized trial of palliative treatment of incurable locally advanced non small cell lung cancer (NSCLC) using radiotherapy (RT) and chemotherapy (CHT) in limited resource setting.
    Jeremic B; Fidarova E; Sharma V; Faheem M; Ameira AA; Nasr Ben Ammar C; Frobe A; Lau F; Brincat S; Jones G
    Radiother Oncol; 2015 Jul; 116(1):21-6. PubMed ID: 26163093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliative Care in Lung Cancer: When to Start.
    Bhattacharya P; Dessain SK; Evans TL
    Curr Oncol Rep; 2018 Nov; 20(11):90. PubMed ID: 30414010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.